跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
Lemidna Lenalidomide Capsules 15 mg - NPRA Drug Approval Details
Approvals
/
NPRA
/
Lemidna Lenalidomide Capsules 15 mg
Approved
STANDARD
Lemidna Lenalidomide Capsules 15 mg
NOVUGEN ONCOLOGY SDN. BHD.
🇲🇾 National Pharmaceutical Regulatory Agency
Approval Date
Nov 29, 2025
Approval ID
901a3bb0e9e673d9
Company
NOVUGEN ONCOLOGY SDN. BHD.
Type
Standard
Approval Details
Approval Id
901a3bb0e9e673d9
Drug Approval Npra Name
Lemidna Lenalidomide Capsules 15 mg
Product Name
Lemidna Lenalidomide Capsules 15 mg
Registration Number
MAL25096040AE
Holder Company Name
NOVUGEN ONCOLOGY SDN. BHD.
Holder Address
NO. 3, JALAN JURURANCANG U1/21 HICOM GLENMARIE INDUSTRIAL PARK 40150 SHAH ALAM MALAYSIA
Holder Phone
60358702243
Manufacturer Company Name
NOVUGEN ONCOLOGY SDN. BHD.
Manufacturer Address
NO. 47, JALAN LENGKUK TEKNOLOGI 2 TAMAN TEKNOLOGI ENSTEK FASA 1 TECHPARK@ENSTEK 71760 BANDAR ENSTEK MALAYSIA
Source Url
https://quest3plus.bpfk.gov.my/pmo2/detail.php?type=product&id=MAL25096040AE
Version
1764410873
Active Ingredients
Approved
Quick Info
Agency
NPRA
Country
🇲🇾
Approval Date
Nov 29, 2025
Approval ID
901a3bb0e9e673d9
Type
Standard
Source
Official Source
Back to NPRA Approvals